CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxTelehealth weight loss program with low entry-tier semaglutide pricing and a separate program fee for tirzepatide.
Visit Ivim HealthCoreAge Rx takes it with a higher Verdict Score — 94/100 to 63/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Ivim Health still earns its place — budget-conscious shoppers.
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
| Metric | CoreAge Rx | Ivim Health |
|---|---|---|
| Verdict Score | 94/100 | 63/100 |
| Grade | A | C |
| Semaglutide | $149/mo | From $149/mo (starting dose, medication and programme fee, compounded) |
| Tirzepatide | $349/mo | From $224/mo (starting dose, medication and programme fee, compounded) |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
What we like
The caveats
What we like
The caveats
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for Ivim Health does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.